Insulin signaling, glucose metabolism and mitochondria: Major players in Alzheimer's disease and diabetes interrelation

Brain Research

Volumn 1441, Issue , 2012, Pages 64-78

  Correia, Sónia C ^a,b   Santos, Renato X ^a,b   Carvalho, Cristina ^a,b   Cardoso, Susana ^a,b   Candeias, Emanuel ^a,b   Santos, Maria S ^a,b   Oliveira, Catarina R ^a,c   Moreira, Paula I ^a,d  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Alzheimer's disease; Cerebral glucose metabolism; Diabetes; Insulin signaling; Mitochondria; Oxidative stress

Indexed keywords

AMYLIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; CALCIUM ION; CYTOCHROME C OXIDASE; GAMMA SECRETASE; GLUCOSE; INSULIN; INSULINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN C; TAU PROTEIN;

ALZHEIMER DISEASE; AMYLOIDOSIS; CALCIUM HOMEOSTASIS; COGNITIVE DEFECT; DIABETES MELLITUS; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME REGULATION; EXTRACELLULAR SPACE; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HORMONE ACTION; HUMAN; HYPERINSULINEMIA; IMMUNOREACTIVITY; INSULIN DEFICIENCY; INSULIN RESISTANCE; INSULIN SIGNALING; LONG TERM POTENTIATION; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRION; NERVE CELL PLASTICITY; NERVE DEGENERATION; NONHUMAN; OLIGOMERIZATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; REVIEW; SENILE PLAQUE; TRANS GOLGI NETWORK;

ALZHEIMER DISEASE; ANIMALS; DIABETES MELLITUS, TYPE 2; GLUCOSE; HUMANS; INSULIN; MITOCHONDRIA; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 84857788978     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.12.063     Document Type: Review

References (199)

1. T. Akisaki, T. Sakurai, T. Takata, H. Umegaki, A. Araki, S. Mizuno, S. Tanaka, Y. Ohashi, A. Iguchi, K. Yokono, and H. Ito Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT) Diabetes Metab. Res. Rev. 22 2006 376 384 (Pubitemid 44446433)
2. K.V. Allen, B.M. Frier, and M.W. Strachan The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations Eur. J. Pharmacol. 490 2004 169 175 (Pubitemid 38482170)
3. H.K. Anandatheerthavarada, G. Biswas, M.A. Robin, and N.G. Avadhani Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells J. Cell Biol. 161 2003 41 54 (Pubitemid 36459078)
4. M. Anello, R. Lupi, D. Spampinato, S. Piro, M. Masini, U. Boggi, S. Del Prato, A.M. Rabuazzo, F. Purrello, and P. Marchetti Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients Diabetologia 48 2005 282 289 (Pubitemid 40543300)
5. M. Anguiano, R.J. Nowak, and P.T. Lansbury Jr. Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes Biochemistry 41 2002 11338 11343
6. L.D. Baker, D.J. Cross, S. Minoshima, D. Belongia, G.S. Watson, and S. Craft Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes Arch. Neurol. 68 2011 51 57
7. M.F. Beal Mitochondria take center stage in aging and neurodegeneration Ann. Neurol. 58 2005 495 505 (Pubitemid 41377212)
8. C. Betsholtz, L. Christmansson, U. Engstrom, F. Rorsman, V. Svensson, K.H. Johnson, and P. Westermark Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species FEBS Lett. 251 1989 261 264 (Pubitemid 19181881)
9. I. Bezprozvanny, and M.P. Mattson Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease Trends Neurosci. 31 2008 454 463
10. G.J. Biessels, A. Kamal, I.J. Urban, B.M. Spruijt, D.W. Erkelens, and W.H. Gispen Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment Brain Res. 800 1998 125 135 (Pubitemid 28361929)
11. G.J. Biessels, I.J. Deary, and C.M. Ryan Cognition and diabetes: a lifespan perspective Lancet Neurol. 7 2008 184 190
12. F. Bosetti, F. Brizzi, S. Barogi, M. Mancuso, G. Siciliano, E.A. Tendi, L. Murri, S.I. Rapoport, and G. Solaini Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease Neurobiol. Aging 23 2002 371 376 (Pubitemid 34312019)
13. H. Braak, and E. Braak Staging of Alzheimer's disease-related neurofibrillary changes Neurobiol. Aging 16 1995 271 278 discussion 278-84
14. A.M. Brands, G.J. Biessels, E.H. de Haan, L.J. Kappelle, and R.P. Kessels The effects of type 1 diabetes on cognitive performance: a meta-analysis Diabetes Care 28 2005 726 735 (Pubitemid 40315341)
15. A.J. Bruce-Keller, Y.J. Li, M.A. Lovell, P.J. Kraemer, D.S. Gary, R.R. Brown, W.R. Markesbery, and M.P. Mattson 4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats J. Neuropathol. Exp. Neurol. 57 1998 257 267 (Pubitemid 28125506)
16. P. Bubber, V. Haroutunian, G. Fisch, J.P. Blass, and G.E. Gibson Mitochondrial abnormalities in Alzheimer brain: mechanistic implications Ann. Neurol. 57 2005 695 703 (Pubitemid 40628858)
17. R. Bucala, and A. Cerami Advanced glycosylation: chemistry, biology, and implications for diabetes and aging Adv. Pharmacol. 23 1992 1 34
18. G. Bucht, R. Adolfsson, F. Lithner, and B. Winblad Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type Acta Med. Scand. 213 1983 387 392 (Pubitemid 13062562)
19. S. Cardoso, S. Correia, R.X. Santos, C. Carvalho, M.S. Santos, C.R. Oliveira, G. Perry, M.A. Smith, X. Zhu, and P.I. Moreira Insulin is a two-edged knife on the brain J. Alzheimers Dis. 18 2009 483 507
20. S. Cardoso, C. Carvalho, R. Santos, S. Correia, M.S. Santos, R. Seica, C.R. Oliveira, and P.I. Moreira Impact of STZ-induced hyperglycemia and insulin-induced hypoglycemia in plasma amino acids and cortical synaptosomal neurotransmitters Synapse 2010
21. S. Cardoso, M.S. Santos, R. Seica, and P.I. Moreira Cortical and hippocampal mitochondria bioenergetics and oxidative status during hyperglycemia and/or insulin-induced hypoglycemia Biochim. Biophys. Acta 1802 2010 942 951
22. C. Caspersen, N. Wang, J. Yao, A. Sosunov, X. Chen, J.W. Lustbader, H.W. Xu, D. Stern, G. McKhann, and S.D. Yan Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease FASEB J. 19 2005 2040 2041 (Pubitemid 41759758)
23. R.J. Castellani, P.L. Harris, L.M. Sayre, J. Fujii, N. Taniguchi, M.P. Vitek, H. Founds, C.S. Atwood, G. Perry, and M.A. Smith Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine Free Radic. Biol. Med. 31 2001 175 180 (Pubitemid 32607584)
24. R.J. Castellani, R.K. Rolston, and M.A. Smith Alzheimer disease Dis. Mon. 56 2010 484 546
25. H. Chen, and D.C. Chan Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases Hum. Mol. Genet. 18 2009 R169 R176
26. C.M. Cheng, V. Tseng, J. Wang, D. Wang, L. Matyakhina, and C.A. Bondy Tau is hyperphosphorylated in the insulin-like growth factor-I null brain Endocrinology 146 2005 5086 5091 (Pubitemid 41653021)
27. F. Chiti, and C.M. Dobson Protein misfolding, functional amyloid, and human disease Annu. Rev. Biochem. 75 2006 333 366 (Pubitemid 44118036)
28. G.D. Ciccotosto, D.J. Tew, S.C. Drew, D.G. Smith, T. Johanssen, V. Lal, T.L. Lau, K. Perez, C.C. Curtain, J.D. Wade, F. Separovic, C.L. Masters, J.P. Smith, K.J. Barnham, and R. Cappai Stereospecific interactions are necessary for Alzheimer disease amyloid-beta toxicity Neurobiol. Aging 32 2011 235 248
29. A. Clark, and M.R. Nilsson Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes? Diabetologia 47 2004 157 169 (Pubitemid 38315352)
30. A. Clark, C.A. Wells, I.D. Buley, J.K. Cruickshank, R.I. Vanhegan, D.R. Matthews, G.J. Cooper, R.R. Holman, and R.C. Turner Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes Diabetes Res. 9 1988 151 159 (Pubitemid 19105415)
31. J.P. Cleary, D.M. Walsh, J.J. Hofmeister, G.M. Shankar, M.A. Kuskowski, D.J. Selkoe, and K.H. Ashe Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function Nat. Neurosci. 8 2005 79 84 (Pubitemid 41236735)
32. G.J. Cooper Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease Endocr. Rev. 15 1994 163 201 (Pubitemid 24129182)
33. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L. Haines, and M.A. Pericak-Vance Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 1993 921 923 (Pubitemid 23275809)
34. S. Craft, E. Peskind, M.W. Schwartz, G.D. Schellenberg, M. Raskind, and D. Porte Jr. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype Neurology 50 1998 164 168
35. D.A. Cross, D.R. Alessi, P. Cohen, M. Andjelkovich, and B.A. Hemmings Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B Nature 378 1995 785 789 (Pubitemid 26004411)
36. P.J. Crouch, R. Blake, J.A. Duce, G.D. Ciccotosto, Q.X. Li, K.J. Barnham, C.C. Curtain, R.A. Cherny, R. Cappai, T. Dyrks, C.L. Masters, and I.A. Trounce Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42 J. Neurosci. 25 2005 672 679
37. M.P. Cuajungco, and K.Y. Faget Zinc takes the center stage: its paradoxical role in Alzheimer's disease Brain Res. Brain Res. Rev. 41 2003 44 56 (Pubitemid 36044593)
38. R.G. Cutler, J. Kelly, K. Storie, W.A. Pedersen, A. Tammara, K. Hatanpaa, J.C. Troncoso, and M.P. Mattson Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 101 2004 2070 2075 (Pubitemid 38229016)
39. F.G. De Felice, P.T. Velasco, M.P. Lambert, K. Viola, S.J. Fernandez, S.T. Ferreira, and W.L. Klein Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine J. Biol. Chem. 282 2007 11590 11601 (Pubitemid 47100810)
40. F.G. De Felice, M.N. Vieira, T.R. Bomfim, H. Decker, P.T. Velasco, M.P. Lambert, K.L. Viola, W.Q. Zhao, S.T. Ferreira, and W.L. Klein Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers Proc. Natl. Acad. Sci. U. S. A. 106 2009 1971 1976
41. S.M. de la Monte, and J.R. Wands Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease J. Alzheimers Dis. 7 2005 45 61 (Pubitemid 40387184)
42. R.N. DeJong CNS manifestations of diabetes mellitus Postgrad. Med. 61 1977 101 107
43. T. den Heijer, S.E. Vermeer, E.J. van Dijk, N.D. Prins, P.J. Koudstaal, A. Hofman, and M.M. Breteler Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI Diabetologia 46 2003 1604 1610 (Pubitemid 38005322)
44. L. Devi, B.M. Prabhu, D.F. Galati, N.G. Avadhani, and H.K. Anandatheerthavarada Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction J. Neurosci. 26 2006 9057 9068 (Pubitemid 44319397)
45. J.L. Edwards, A. Quattrini, S.I. Lentz, C. Figueroa-Romero, F. Cerri, C. Backus, Y. Hong, and E.L. Feldman Diabetes regulates mitochondrial biogenesis and fission in mouse neurons Diabetologia 53 2010 160 169
46. P. Fernyhough, S.K. Roy Chowdhury, and R.E. Schmidt Mitochondrial stress and the pathogenesis of diabetic neuropathy Expert Rev. Endocrinol. Metab. 5 2010 39 49
47. S. Freude, L. Plum, J. Schnitker, U. Leeser, M. Udelhoven, W. Krone, J.C. Bruning, and M. Schubert Peripheral hyperinsulinemia promotes tau phosphorylation in vivo Diabetes 54 2005 3343 3348 (Pubitemid 43334322)
48. L. Frolich, D. Blum-Degen, H.G. Bernstein, S. Engelsberger, J. Humrich, S. Laufer, D. Muschner, A. Thalheimer, A. Turk, S. Hoyer, R. Zochling, K.W. Boissl, K. Jellinger, and P. Riederer Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease J. Neural Transm. 105 1998 423 438 (Pubitemid 28365027)
49. L. Gasparini, and H. Xu Potential roles of insulin and IGF-1 in Alzheimer's disease Trends Neurosci. 26 2003 404 406 (Pubitemid 37288973)
50. L. Gasparini, G.K. Gouras, R. Wang, R.S. Gross, M.F. Beal, P. Greengard, and H. Xu Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling J. Neurosci. 21 2001 2561 2570 (Pubitemid 32298198)
51. L. Gasparini, W.J. Netzer, P. Greengard, and H. Xu Does insulin dysfunction play a role in Alzheimer's disease? Trends Pharmacol. Sci. 23 2002 288 293 (Pubitemid 34655735)
52. A. Gasser, and J.M. Forbes Advanced glycation: implications in tissue damage and disease Protein Pept. Lett. 15 2008 385 391 (Pubitemid 351679341)
53. S. Gebre-Medhin, H. Mulder, M. Pekny, G. Westermark, J. Tornell, P. Westermark, F. Sundler, B. Ahren, and C. Betsholtz Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin) Biochem. Biophys. Res. Commun. 250 1998 271 277 (Pubitemid 28463867)
54. X. Girones, A. Guimera, C.Z. Cruz-Sanchez, A. Ortega, N. Sasaki, Z. Makita, J.V. Lafuente, R. Kalaria, and F.F. Cruz-Sanchez N epsilon- carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease Free Radic. Biol. Med. 36 2004 1241 1247 (Pubitemid 38526318)
55. M. Goedert, and M.G. Spillantini A century of Alzheimer's disease Science 314 2006 777 781 (Pubitemid 44706636)
56. S.Y. Goh, and M.E. Cooper Clinical review: the role of advanced glycation end products in progression and complications of diabetes J. Clin. Endocrinol. Metab. 93 2008 1143 1152 (Pubitemid 351519698)
57. J.D. Green, C. Goldsbury, J. Kistler, G.J. Cooper, and U. Aebi Human amylin oligomer growth and fibril elongation define two distinct phases in amyloid formation J. Biol. Chem. 279 2004 12206 12212 (Pubitemid 38445785)
58. E. Grunblatt, M. Salkovic-Petrisic, J. Osmanovic, P. Riederer, and S. Hoyer Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein J. Neurochem. 101 2007 757 770 (Pubitemid 46633313)
59. L. Haataja, T. Gurlo, C.J. Huang, and P.C. Butler Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis Endocr. Rev. 29 2008 303 316 (Pubitemid 351679701)
60. C.A. Hansson Petersen, N. Alikhani, H. Behbahani, B. Wiehager, P.F. Pavlov, I. Alafuzoff, V. Leinonen, A. Ito, B. Winblad, E. Glaser, and M. Ankarcrona The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae Proc. Natl. Acad. Sci. U. S. A. 105 2008 13145 13150
61. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356 (Pubitemid 34790756)
62. M. Hashimoto, E. Rockenstein, L. Crews, and E. Masliah Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases Neuromolecular Med. 4 2003 21 36
63. J. Heitner, and D. Dickson Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study Neurology 49 1997 1306 1311 (Pubitemid 27495634)
64. K. Hensley, R.A. Floyd, N.Y. Zheng, R. Nael, K.A. Robinson, X. Nguyen, Q.N. Pye, C.A. Stewart, J. Geddes, W.R. Markesbery, E. Patel, G.V. Johnson, and G. Bing p38 kinase is activated in the Alzheimer's disease brain J. Neurochem. 72 1999 2053 2058 (Pubitemid 29186010)
65. K. Hirai, G. Aliev, A. Nunomura, H. Fujioka, R.L. Russell, C.S. Atwood, A.B. Johnson, Y. Kress, H.V. Vinters, M. Tabaton, S. Shimohama, A.D. Cash, S.L. Siedlak, P.L. Harris, P.K. Jones, R.B. Petersen, G. Perry, and M.A. Smith Mitochondrial abnormalities in Alzheimer's disease J. Neurosci. 21 2001 3017 3023 (Pubitemid 32323483)
66. L. Ho, W. Qin, P.N. Pompl, Z. Xiang, J. Wang, Z. Zhao, Y. Peng, G. Cambareri, A. Rocher, C.V. Mobbs, P.R. Hof, and G.M. Pasinetti Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease FASEB J. 18 2004 902 904
67. M. Hong, and V.M. Lee Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons J. Biol. Chem. 272 1997 19547 19553 (Pubitemid 27337756)
68. C.R. Hooijmans, C. Graven, P.J. Dederen, H. Tanila, T. van Groen, and A.J. Kiliaan Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice Brain Res. 1181 2007 93 103 (Pubitemid 350050914)
69. X. Hou, Z. Ling, E. Quartier, A. Foriers, F. Schuit, D. Pipeleers, and C. Van Schravendijk Prolonged exposure of pancreatic beta cells to raised glucose concentrations results in increased cellular content of islet amyloid polypeptide precursors Diabetologia 42 1999 188 194 (Pubitemid 29064241)
70. S. Hoyer Causes and consequences of disturbances of cerebral glucose metabolism in sporadic Alzheimer disease: therapeutic implications Adv. Exp. Med. Biol. 541 2004 135 152 (Pubitemid 38037371)
71. S. Hoyer, and R. Nitsch Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer type J. Neural Transm. 75 1989 227 232 (Pubitemid 19039949)
72. H.M. Huang, H.C. Ou, H. Xu, H.L. Chen, C. Fowler, and G.E. Gibson Inhibition of alpha-ketoglutarate dehydrogenase complex promotes cytochrome c release from mitochondria, caspase-3 activation, and necrotic cell death J. Neurosci. Res. 74 2003 309 317 (Pubitemid 37193717)
73. C.J. Huang, C.Y. Lin, L. Haataja, T. Gurlo, A.E. Butler, R.A. Rizza, and P.C. Butler High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes Diabetes 56 2007 2016 2027 (Pubitemid 47201819)
74. F. Irie, A.L. Fitzpatrick, O.L. Lopez, L.H. Kuller, R. Peila, A.B. Newman, and L.J. Launer Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study Arch. Neurol. 65 2008 89 93
75. J. Janson, W.C. Soeller, P.C. Roche, R.T. Nelson, A.J. Torchia, D.K. Kreutter, and P.C. Butler Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide Proc. Natl. Acad. Sci. U. S. A. 93 1996 7283 7288 (Pubitemid 26243541)
76. J. Janson, T. Laedtke, J.E. Parisi, P. O'Brien, R.C. Petersen, and P.C. Butler Increased risk of type 2 diabetes in Alzheimer disease Diabetes 53 2004 474 481 (Pubitemid 38174565)
77. J.T. Jarrett, E.P. Berger, and P.T. Lansbury Jr. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease Biochemistry 32 1993 4693 4697 (Pubitemid 23162022)
78. G.V. Johnson, T.M. Cox, J.P. Lockhart, M.D. Zinnerman, M.L. Miller, and R.E. Powers Transglutaminase activity is increased in Alzheimer's disease brain Brain Res. 751 1997 323 329 (Pubitemid 27132565)
79. C.G. Jolivalt, C.A. Lee, K.K. Beiswenger, J.L. Smith, M. Orlov, M.A. Torrance, and E. Masliah Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin J. Neurosci. Res. 86 2008 3265 3274
80. C.G. Jolivalt, R. Hurford, C.A. Lee, W. Dumaop, E. Rockenstein, and E. Masliah Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice Exp. Neurol. 223 2010 422 431
81. S.E. Kahn, S. Andrikopoulos, and C.B. Verchere Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes Diabetes 48 1999 241 253 (Pubitemid 29061094)
82. O. Kann, and R. Kovacs Mitochondria and neuronal activity Am. J. Physiol. Cell Physiol. 292 2007 C641 C657
83. R. Kayed, E. Head, J.L. Thompson, T.M. McIntire, S.C. Milton, C.W. Cotman, and C.G. Glabe Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 2003 486 489 (Pubitemid 36444329)
84. R. Kayed, Y. Sokolov, B. Edmonds, T.M. McIntire, S.C. Milton, J.E. Hall, and C.G. Glabe Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases J. Biol. Chem. 279 2004 46363 46366 (Pubitemid 39518276)
85. I. Kelleher, C. Garwood, D.P. Hanger, B.H. Anderton, and W. Noble Kinase activities increase during the development of tauopathy in htau mice J. Neurochem. 103 2007 2256 2267 (Pubitemid 350173566)
86. J.N. Keller, R.J. Mark, A.J. Bruce, E. Blanc, J.D. Rothstein, K. Uchida, G. Waeg, and M.P. Mattson 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes Neuroscience 80 1997 685 696 (Pubitemid 27334614)
87. B. Kim, C. Backus, S. Oh, J.M. Hayes, and E.L. Feldman Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes Endocrinology 150 2009 5294 5301
88. M.D. Kirkitadze, and A. Kowalska Molecular mechanisms initiating amyloid beta-fibril formation in Alzheimer's disease Acta Biochim. Pol. 52 2005 417 423 (Pubitemid 41133776)
89. S.J. Kish, C. Bergeron, A. Rajput, S. Dozic, F. Mastrogiacomo, L.J. Chang, J.M. Wilson, L.M. DiStefano, and J.N. Nobrega Brain cytochrome oxidase in Alzheimer's disease J. Neurochem. 59 1992 776 779
90. M. Kivipelto, E.L. Helkala, M.P. Laakso, T. Hanninen, M. Hallikainen, K. Alhainen, S. Iivonen, A. Mannermaa, J. Tuomilehto, A. Nissinen, and H. Soininen Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease Ann. Intern. Med. 137 2002 149 155 (Pubitemid 34827510)
91. Z. Kroner The relationship between Alzheimer's disease and diabetes: type 3 diabetes? Altern. Med. Rev. 14 2009 373 379
92. P.N. Lacor, M.C. Buniel, P.W. Furlow, A.S. Clemente, P.T. Velasco, M. Wood, K.L. Viola, and W.L. Klein Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease J. Neurosci. 27 2007 796 807 (Pubitemid 46174498)
93. M.P. Lambert, A.K. Barlow, B.A. Chromy, C. Edwards, R. Freed, M. Liosatos, T.E. Morgan, I. Rozovsky, B. Trommer, K.L. Viola, P. Wals, C. Zhang, C.E. Finch, G.A. Krafft, and W.L. Klein Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins Proc. Natl. Acad. Sci. U. S. A. 95 1998 6448 6453
94. J. Lauren, D.A. Gimbel, H.B. Nygaard, J.W. Gilbert, and S.M. Strittmatter Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers Nature 457 2009 1128 1132
95. M.C. Leal, A. Fernandez Gamba, L. Morelli, and E.M. Castano Cerebral proteolysis of amiloid-b peptide: relevance of insulin-degrading enzyme in Alzheimer's disease Medicina (B Aires) 69 2009 466 472
96. M.D. Ledesma, P. Bonay, C. Colaco, and J. Avila Analysis of microtubule-associated protein tau glycation in paired helical filaments J. Biol. Chem. 269 1994 21614 21619 (Pubitemid 24274797)
97. G.M. Leinninger, C. Backus, A.M. Sastry, Y.B. Yi, C.W. Wang, and E.L. Feldman Mitochondria in DRG neurons undergo hyperglycemic mediated injury through Bim, Bax and the fission protein Drp1 Neurobiol. Dis. 23 2006 11 22 (Pubitemid 44192383)
98. M.A. Leissring, W. Farris, A.Y. Chang, D.M. Walsh, X. Wu, X. Sun, M.P. Frosch, and D.J. Selkoe Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death Neuron 40 2003 1087 1093 (Pubitemid 38032786)
99. S. Lesne, M.T. Koh, L. Kotilinek, R. Kayed, C.G. Glabe, A. Yang, M. Gallagher, and K.H. Ashe A specific amyloid-beta protein assembly in the brain impairs memory Nature 440 2006 352 357
100. M. Lesort, and G.V. Johnson Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons Neuroscience 99 2000 305 316 (Pubitemid 30628418)
101. L. Li, and C. Holscher Common pathological processes in Alzheimer disease and type 2 diabetes: a review Brain Res. Rev. 56 2007 384 402 (Pubitemid 350166529)
102. Z.G. Li, W. Zhang, G. Grunberger, and A.A. Sima Hippocampal neuronal apoptosis in type 1 diabetes Brain Res. 946 2002 221 231 (Pubitemid 34876334)
103. Z.G. Li, W. Zhang, and A.A. Sima Alzheimer-like changes in rat models of spontaneous diabetes Diabetes 56 2007 1817 1824 (Pubitemid 47025451)
104. Y.A. Lim, L.M. Ittner, Y.L. Lim, and J. Gotz Human but not rat amylin shares neurotoxic properties with Abeta42 in long-term hippocampal and cortical cultures FEBS Lett. 582 2008 2188 2194
105. Y. Liu, F. Liu, K. Iqbal, I. Grundke-Iqbal, and C.X. Gong Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease FEBS Lett. 582 2008 359 364
106. S. Luca, W.M. Yau, R. Leapman, and R. Tycko Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR Biochemistry 46 2007 13505 13522 (Pubitemid 350209947)
107. J.A. Luchsinger, C. Reitz, B. Patel, M.X. Tang, J.J. Manly, and R. Mayeux Relation of diabetes to mild cognitive impairment Arch. Neurol. 64 2007 570 575 (Pubitemid 46588347)
108. L.F. Lue, Y.M. Kuo, A.E. Roher, L. Brachova, Y. Shen, L. Sue, T. Beach, J.H. Kurth, R.E. Rydel, and J. Rogers Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease Am. J. Pathol. 155 1999 853 862 (Pubitemid 29426831)
109. J.W. Lustbader, M. Cirilli, C. Lin, H.W. Xu, K. Takuma, N. Wang, C. Caspersen, X. Chen, S. Pollak, M. Chaney, F. Trinchese, S. Liu, F. Gunn-Moore, L.F. Lue, D.G. Walker, P. Kuppusamy, Z.L. Zewier, O. Arancio, D. Stern, S.S. Yan, and H. Wu ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease Science 304 2004 448 452 (Pubitemid 38495942)
110. M. Manczak, T.S. Anekonda, E. Henson, B.S. Park, J. Quinn, and P.H. Reddy Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression Hum. Mol. Genet. 15 2006 1437 1449
111. C.A. Manning, M.E. Ragozzino, and P.E. Gold Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer's type Neurobiol. Aging 14 1993 523 528 (Pubitemid 23347883)
112. S.M. Manschot, A.M. Brands, J. van der Grond, R.P. Kessels, A. Algra, L.J. Kappelle, and G.J. Biessels Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes Diabetes 55 2006 1106 1113 (Pubitemid 44100188)
113. L. Marzban, G. Trigo-Gonzalez, and C.B. Verchere Processing of pro-islet amyloid polypeptide in the constitutive and regulated secretory pathways of beta cells Mol. Endocrinol. 19 2005 2154 2163 (Pubitemid 41124209)
114. L. Marzban, C.J. Rhodes, D.F. Steiner, L. Haataja, P.A. Halban, and C.B. Verchere Impaired NH2-terminal processing of human proislet amyloid polypeptide by the prohormone convertase PC2 leads to amyloid formation and cell death Diabetes 55 2006 2192 2201 (Pubitemid 44743615)
115. L. Marzban, A. Tomas, T.C. Becker, L. Rosenberg, J. Oberholzer, P.E. Fraser, P.A. Halban, and C.B. Verchere Small interfering RNA-mediated suppression of proislet amyloid polypeptide expression inhibits islet amyloid formation and enhances survival of human islets in culture Diabetes 57 2008 3045 3055
116. R. Mastrocola, F. Restivo, I. Vercellinatto, O. Danni, E. Brignardello, M. Aragno, and G. Boccuzzi Oxidative and nitrosative stress in brain mitochondria of diabetic rats J. Endocrinol. 187 2005 37 44 (Pubitemid 41556399)
117. M.P. Mattson, D.S. Gary, S.L. Chan, and W. Duan Perturbed endoplasmic reticulum function, synaptic apoptosis and the pathogenesis of Alzheimer's disease Biochem. Soc. Symp. 2001 151 162 (Pubitemid 33602683)
118. M.P. Mattson, M. Gleichmann, and A. Cheng Mitochondria in neuroplasticity and neurological disorders Neuron 60 2008 748 766
119. C.A. McLean, R.A. Cherny, F.W. Fraser, S.J. Fuller, M.J. Smith, K. Beyreuther, A.I. Bush, and C.L. Masters Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease Ann. Neurol. 46 1999 860 866
120. J.J. Meier, R. Kayed, C.Y. Lin, T. Gurlo, L. Haataja, S. Jayasinghe, R. Langen, C.G. Glabe, and P.C. Butler Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP Am. J. Physiol. Endocrinol. Metab. 291 2006 E1317 E1324
121. T.A. Mirzabekov, M.C. Lin, and B.L. Kagan Pore formation by the cytotoxic islet amyloid peptide amylin J. Biol. Chem. 271 1996 1988 1992 (Pubitemid 26047780)
122. P.I. Moreira, M.S. Santos, A.M. Moreno, R. Seica, and C.R. Oliveira Increased vulnerability of brain mitochondria in diabetic (Goto-Kakizaki) rats with aging and amyloid-beta exposure Diabetes 52 2003 1449 1456 (Pubitemid 36666200)
123. P.I. Moreira, M.S. Santos, C. Sena, R. Seica, and C.R. Oliveira Insulin protects against amyloid beta-peptide toxicity in brain mitochondria of diabetic rats Neurobiol. Dis. 18 2005 628 637 (Pubitemid 40332720)
124. P.I. Moreira, A.P. Rolo, C. Sena, R. Seica, C.R. Oliveira, and M.S. Santos Insulin attenuates diabetes-related mitochondrial alterations: a comparative study Med. Chem. 2 2006 299 308 (Pubitemid 44083149)
125. P.I. Moreira, P.L. Harris, X. Zhu, M.S. Santos, C.R. Oliveira, M.A. Smith, and G. Perry Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts J. Alzheimers Dis. 12 2007 195 206 (Pubitemid 47509369)
126. P.I. Moreira, M.S. Santos, and C.R. Oliveira Alzheimer's disease: a lesson from mitochondrial dysfunction Antioxid. Redox Signal. 9 2007 1621 1630 (Pubitemid 47462966)
127. P.I. Moreira, S.L. Siedlak, X. Wang, M.S. Santos, C.R. Oliveira, M. Tabaton, A. Nunomura, L.I. Szweda, G. Aliev, M.A. Smith, X. Zhu, and G. Perry Increased autophagic degradation of mitochondria in Alzheimer disease Autophagy 3 2007 614 615 (Pubitemid 350060061)
128. P.I. Moreira, A.I. Duarte, M.S. Santos, A.C. Rego, and C.R. Oliveira An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease J. Alzheimers Dis. 16 2009 741 761
129. L. Mosconi, S. De Santi, J. Li, W.H. Tsui, Y. Li, M. Boppana, E. Laska, H. Rusinek, and M.J. de Leon Hippocampal hypometabolism predicts cognitive decline from normal aging Neurobiol. Aging 29 2008 676 692 (Pubitemid 351400830)
130. L. Munoz, and A.J. Ammit Targeting p38 MAPK pathway for the treatment of Alzheimer's disease Neuropharmacology 58 2010 561 568
131. F.E. Murray, J.P. Landsberg, R.J. Williams, M.M. Esiri, and F. Watt Elemental analysis of neurofibrillary tangles in Alzheimer's disease using proton-induced X-ray analysis Ciba Found Symp. 169 1992 201 210 discussion 210-6
132. K.A. Nielson, J.H. Nolan, N.C. Berchtold, C.A. Sandman, R.A. Mulnard, and C.W. Cotman Apolipoprotein-E genotyping of diabetic dementia patients: is diabetes rare in Alzheimer's disease? J. Am. Geriatr. Soc. 44 1996 897 904 (Pubitemid 26287143)
133. W. Noble, E. Planel, C. Zehr, V. Olm, J. Meyerson, F. Suleman, K. Gaynor, L. Wang, J. LaFrancois, B. Feinstein, M. Burns, P. Krishnamurthy, Y. Wen, R. Bhat, J. Lewis, D. Dickson, and K. Duff Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo Proc. Natl. Acad. Sci. U. S. A. 102 2005 6990 6995 (Pubitemid 40675429)
134. A. Nunomura, G. Perry, M.A. Pappolla, R. Wade, K. Hirai, S. Chiba, and M.A. Smith RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease J. Neurosci. 19 1999 1959 1964 (Pubitemid 29133374)
135. A. Nunomura, G. Perry, G. Aliev, K. Hirai, A. Takeda, E.K. Balraj, P.K. Jones, H. Ghanbari, T. Wataya, S. Shimohama, S. Chiba, C.S. Atwood, R.B. Petersen, and M.A. Smith Oxidative damage is the earliest event in Alzheimer disease J. Neuropathol. Exp. Neurol. 60 2001 759 767 (Pubitemid 32678256)
136. A. Nunomura, K. Honda, A. Takeda, K. Hirai, X. Zhu, M.A. Smith, and G. Perry Oxidative damage to RNA in neurodegenerative diseases J. Biomed. Biotechnol. 2006 2006 82323
137. N. Origlia, M. Righi, S. Capsoni, A. Cattaneo, F. Fang, D.M. Stern, J.X. Chen, A.M. Schmidt, O. Arancio, S.D. Yan, and L. Domenici Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction J. Neurosci. 28 2008 3521 3530 (Pubitemid 351469321)
138. A. Ott, R.P. Stolk, F. van Harskamp, H.A. Pols, A. Hofman, and M.M. Breteler Diabetes mellitus and the risk of dementia: The Rotterdam Study Neurology 53 1999 1937 1942
139. J. Pahnke, L.C. Walker, K. Scheffler, and M. Krohn Alzheimer's disease and blood-brain barrier function-why have anti-beta-amyloid therapies failed to prevent dementia progression? Neurosci. Biobehav. Rev. 33 2009 1099 1108
140. W.D. Parker Jr., N.J. Mahr, C.M. Filley, J.K. Parks, D. Hughes, D.A. Young, and C.M. Cullum Reduced platelet cytochrome c oxidase activity in Alzheimer's disease Neurology 44 1994 1086 1090 (Pubitemid 24188183)
141. F. Pasquier, A. Boulogne, D. Leys, and P. Fontaine Diabetes mellitus and dementia Diabetes Metab. 32 2006 403 414 (Pubitemid 44841847)
142. J.F. Paulsson, and G.T. Westermark Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formation Diabetes 54 2005 2117 2125 (Pubitemid 40911275)
143. W.A. Pedersen, P.J. McMillan, J.J. Kulstad, J.B. Leverenz, S. Craft, and G.R. Haynatzki Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice Exp. Neurol. 199 2006 265 273 (Pubitemid 43928978)
144. J.J. Pei, E. Braak, H. Braak, I. Grundke-Iqbal, K. Iqbal, B. Winblad, and R.F. Cowburn Localization of active forms of C-jun kinase (JNK) and p38 kinase in Alzheimer's disease brains at different stages of neurofibrillary degeneration J. Alzheimers Dis. 3 2001 41 48 (Pubitemid 32238249)
145. J.J. Pei, S. Khatoon, W.L. An, M. Nordlinder, T. Tanaka, H. Braak, I. Tsujio, M. Takeda, I. Alafuzoff, B. Winblad, R.F. Cowburn, I. Grundke-Iqbal, and K. Iqbal Role of protein kinase B in Alzheimer's neurofibrillary pathology Acta Neuropathol. 105 2003 381 392 (Pubitemid 36798832)
146. R. Peila, B.L. Rodriguez, and L.J. Launer Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study Diabetes 51 2002 1256 1262 (Pubitemid 34438377)
147. C.J. Phiel, C.A. Wilson, V.M. Lee, and P.S. Klein GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides Nature 423 2003 435 439 (Pubitemid 36626994)
148. A. Poling, K. Morgan-Paisley, J.J. Panos, E.M. Kim, E. O'Hare, J.P. Cleary, S. Lesne, K.H. Ashe, M. Porritt, and L.E. Baker Oligomers of the amyloid-beta protein disrupt working memory: confirmation with two behavioral procedures Behav. Brain Res. 193 2008 230 234
149. Y. Porat, S. Kolusheva, R. Jelinek, and E. Gazit The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies Biochemistry 42 2003 10971 10977 (Pubitemid 37174388)
150. W.Q. Qiu, and M.F. Folstein Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis Neurobiol. Aging 27 2006 190 198 (Pubitemid 43038542)
151. H.W. Querfurth, and F.M. LaFerla Alzheimer's disease N. Engl. J. Med. 362 2010 329 344
152. H.W. Querfurth, and D.J. Selkoe Calcium ionophore increases amyloid beta peptide production by cultured cells Biochemistry 33 1994 4550 4561 (Pubitemid 24145103)
153. E.M. Reiman, K. Chen, G.E. Alexander, R.J. Caselli, D. Bandy, D. Osborne, A.M. Saunders, and J. Hardy Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia Proc. Natl. Acad. Sci. U. S. A. 101 2004 284 289 (Pubitemid 38084242)
154. E. Reske-Nielsen, and K. Lundbaek Diabetic encephalopathy. Diffuse and focal lesions of the brain in long-term diabetes Acta Neurol. Scand. Suppl. 39 SUPPL. 4 1963 273 290
155. E.J. Rivera, A. Goldin, N. Fulmer, R. Tavares, J.R. Wands, and S.M. de la Monte Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine J. Alzheimers Dis. 8 2005 247 268
156. A. Rocchi, S. Pellegrini, G. Siciliano, and L. Murri Causative and susceptibility genes for Alzheimer's disease: a review Brain Res. Bull. 61 2003 1 24 (Pubitemid 36682979)
157. J.S. Roriz-Filho, T.M. Sa-Roriz, I. Rosset, A.L. Camozzato, A.C. Santos, M.L. Chaves, J.C. Moriguti, and M. Roriz-Cruz (Pre)diabetes, brain aging, and cognition Biochim. Biophys. Acta 1792 2009 432 443
158. M. Salkovic-Petrisic, and S. Hoyer Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach J. Neural Transm. Suppl. 2007 217 233
159. N. Sasaki, R. Fukatsu, K. Tsuzuki, Y. Hayashi, T. Yoshida, N. Fujii, T. Koike, I. Wakayama, R. Yanagihara, R. Garruto, N. Amano, and Z. Makita Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases Am. J. Pathol. 153 1998 1149 1155 (Pubitemid 28465838)
160. A. Scheepers, H.G. Joost, and A. Schurmann The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function JPEN J. Parenter. Enteral. Nutr. 28 2004 364 371 (Pubitemid 39121460)
161. A.M. Schmeichel, J.D. Schmelzer, and P.A. Low Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy Diabetes 52 2003 165 171 (Pubitemid 36042122)
162. R. Schmidt, L.J. Launer, L.G. Nilsson, A. Pajak, S. Sans, K. Berger, M.M. Breteler, M. de Ridder, C. Dufouil, R. Fuhrer, S. Giampaoli, and A. Hofman Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study Diabetes 53 2004 687 692 (Pubitemid 38270638)
163. M. Schubert, D.P. Brazil, D.J. Burks, J.A. Kushner, J. Ye, C.L. Flint, J. Farhang-Fallah, P. Dikkes, X.M. Warot, C. Rio, G. Corfas, and M.F. White Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation J. Neurosci. 23 2003 7084 7092 (Pubitemid 36975873)
164. M. Schubert, D. Gautam, D. Surjo, K. Ueki, S. Baudler, D. Schubert, T. Kondo, J. Alber, N. Galldiks, E. Kustermann, S. Arndt, A.H. Jacobs, W. Krone, C.R. Kahn, and J.C. Bruning Role for neuronal insulin resistance in neurodegenerative diseases Proc. Natl. Acad. Sci. U. S. A. 101 2004 3100 3105 (Pubitemid 38327741)
165. D.J. Selkoe Translating cell biology into therapeutic advances in Alzheimer's disease Nature 399 1999 A23 A31
166. G.M. Shankar, B.L. Bloodgood, M. Townsend, D.M. Walsh, D.J. Selkoe, and B.L. Sabatini Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway J. Neurosci. 27 2007 2866 2875 (Pubitemid 46438992)
167. G.M. Shankar, S. Li, T.H. Mehta, A. Garcia-Munoz, N.E. Shepardson, I. Smith, F.M. Brett, M.A. Farrell, M.J. Rowan, C.A. Lemere, C.M. Regan, D.M. Walsh, B.L. Sabatini, and D.J. Selkoe Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory Nat. Med. 14 2008 837 842
168. M. Shoji, T.E. Golde, J. Ghiso, T.T. Cheung, S. Estus, L.M. Shaffer, X.D. Cai, D.M. McKay, R. Tintner, and B. Frangione Production of the Alzheimer amyloid beta protein by normal proteolytic processing Science 258 1992 126 129
169. J.P. Silva, M. Kohler, C. Graff, A. Oldfors, M.A. Magnuson, P.O. Berggren, and N.G. Larsson Impaired insulin secretion and beta-cell loss in tissue-specific knockout mice with mitochondrial diabetes Nat. Genet. 26 2000 336 340
170. A.A. Sima, and Z.G. Li The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats Diabetes 54 2005 1497 1505 (Pubitemid 40586682)
171. C. Sims-Robinson, B. Kim, A. Rosko, and E.L. Feldman How does diabetes accelerate Alzheimer disease pathology? Nat. Rev. Neurol. 6 2010 551 559
172. M. Sjogren, M. Mielke, D. Gustafson, P. Zandi, and I. Skoog Cholesterol and Alzheimer's disease-is there a relation? Mech. Ageing Dev. 127 2006 138 147 (Pubitemid 43168306)
173. E.M. Snyder, Y. Nong, C.G. Almeida, S. Paul, T. Moran, E.Y. Choi, A.C. Nairn, M.W. Salter, P.J. Lombroso, G.K. Gouras, and P. Greengard Regulation of NMDA receptor trafficking by amyloid-beta Nat. Neurosci. 8 2005 1051 1058 (Pubitemid 41061516)
174. E. Steen, B.M. Terry, E.J. Rivera, J.L. Cannon, T.R. Neely, R. Tavares, X.J. Xu, J.R. Wands, and S.M. de la Monte Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes? J. Alzheimers Dis. 7 2005 63 80 (Pubitemid 40387185)
175. B.A. Stoica, V.A. Movsesyan, P.M.t. Lea, and A.I. Faden Ceramide-induced neuronal apoptosis is associated with dephosphorylation of Akt, BAD, FKHR, GSK-3beta, and induction of the mitochondrial-dependent intrinsic caspase pathway Mol. Cell. Neurosci. 22 2003 365 382 (Pubitemid 36407599)
176. E. Straface, P. Matarrese, L. Gambardella, R. Vona, A. Sgadari, M.C. Silveri, and W. Malorni Oxidative imbalance and cathepsin D changes as peripheral blood biomarkers of Alzheimer disease: a pilot study FEBS Lett. 579 2005 2759 2766 (Pubitemid 40725242)
177. A. Sun, M. Liu, X.V. Nguyen, and G. Bing P38 MAP kinase is activated at early stages in Alzheimer's disease brain Exp. Neurol. 183 2003 394 405 (Pubitemid 37205081)
178. R.H. Swerdlow, J.K. Parks, D.S. Cassarino, D.J. Maguire, R.S. Maguire, J.P. Bennett Jr., R.E. Davis, and W.D. Parker Jr. Cybrids in Alzheimer's disease: a cellular model of the disease? Neurology 49 1997 918 925 (Pubitemid 27456066)
179. K. Takuma, F. Fang, W. Zhang, S. Yan, E. Fukuzaki, H. Du, A. Sosunov, G. McKhann, Y. Funatsu, N. Nakamichi, T. Nagai, H. Mizoguchi, D. Ibi, O. Hori, S. Ogawa, D.M. Stern, K. Yamada, and S.S. Yan RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction Proc. Natl. Acad. Sci. U. S. A. 106 2009 20021 20026
180. C. Toth, A.M. Schmidt, U.I. Tuor, G. Francis, T. Foniok, V. Brussee, J. Kaur, S.F. Yan, J.A. Martinez, P.A. Barber, A. Buchan, and D.W. Zochodne Diabetes, leukoencephalopathy and rage Neurobiol. Dis. 23 2006 445 461 (Pubitemid 44109669)
181. C. Toth, J. Martinez, and D.W. Zochodne RAGE, diabetes, and the nervous system Curr. Mol. Med. 7 2007 766 776
182. M. Townsend, G.M. Shankar, T. Mehta, D.M. Walsh, and D.J. Selkoe Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers J. Physiol. 572 2006 477 492
183. L. Tretter, and V. Adam-Vizi Inhibition of Krebs cycle enzymes by hydrogen peroxide: a key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress J. Neurosci. 20 2000 8972 8979 (Pubitemid 32042897)
184. J. Valla, L. Schneider, T. Niedzielko, K.D. Coon, R. Caselli, M.N. Sabbagh, G.L. Ahern, L. Baxter, G. Alexander, D.G. Walker, and E.M. Reiman Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment Mitochondrion 6 2006 323 330 (Pubitemid 44817367)
185. J. Valla, F. Gonzalez-Lima, and E.M. Reiman FDG autoradiography reveals developmental and pathological effects of mutant amyloid in PDAPP transgenic mice Int. J. Dev. Neurosci. 26 2008 253 258
186. S.J. Vannucci, F. Maher, and I.A. Simpson Glucose transporter proteins in brain: delivery of glucose to neurons and glia Glia 21 1997 2 21 (Pubitemid 27389636)
187. C.B. Verchere, D.A. D'Alessio, R.D. Palmiter, G.C. Weir, S. Bonner-Weir, D.G. Baskin, and S.E. Kahn Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide Proc. Natl. Acad. Sci. U. S. A. 93 1996 3492 3496 (Pubitemid 26125648)
188. H.W. Wang, J.F. Pasternak, H. Kuo, H. Ristic, M.P. Lambert, B. Chromy, K.L. Viola, W.L. Klein, W.B. Stine, G.A. Krafft, and B.L. Trommer Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus Brain Res. 924 2002 133 140 (Pubitemid 34102301)
189. G.S. Watson, and S. Craft Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease Eur. J. Pharmacol. 490 2004 97 113 (Pubitemid 38482164)
190. G.S. Watson, E.R. Peskind, S. Asthana, K. Purganan, C. Wait, D. Chapman, M.W. Schwartz, S. Plymate, and S. Craft Insulin increases CSF Abeta42 levels in normal older adults Neurology 60 2003 1899 1903 (Pubitemid 36736003)
191. P. Westermark, U. Engstrom, K.H. Johnson, G.T. Westermark, and C. Betsholtz Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation Proc. Natl. Acad. Sci. U. S. A. 87 1990 5036 5040
192. G.T. Westermark, P. Westermark, C. Berne, and O. Korsgren Widespread amyloid deposition in transplanted human pancreatic islets N. Engl. J. Med. 359 2008 977 979
193. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 2004 1047 1053 (Pubitemid 38579764)
194. G.P. Wolf-Klein, F.A. Siverstone, M.S. Brod, A. Levy, C.J. Foley, V. Termotto, and J. Breuer Are Alzheimer patients healthier? J. Am. Geriatr. Soc. 36 1988 219 224 (Pubitemid 18078056)
195. S.D. Yan, X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, A. Migheli, P. Nawroth, D. Stern, and A.M. Schmidt RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease Nature 382 1996 685 691 (Pubitemid 26282167)
196. W.Q. Zhao, and D.L. Alkon Role of insulin and insulin receptor in learning and memory Mol. Cell. Endocrinol. 177 2001 125 134 (Pubitemid 32506813)
197. W.Q. Zhao, and M. Townsend Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease Biochim. Biophys. Acta 1792 2009 482 496
198. S. Zraika, R.L. Hull, J. Udayasankar, K.M. Utzschneider, J. Tong, F. Gerchman, and S.E. Kahn Glucose- and time-dependence of islet amyloid formation in vitro Biochem. Biophys. Res. Commun. 354 2007 234 239 (Pubitemid 46123224)
199. S. Zraika, R.L. Hull, J. Udayasankar, K. Aston-Mourney, S.L. Subramanian, R. Kisilevsky, W.A. Szarek, and S.E. Kahn Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis Diabetologia 52 2009 626 635